Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Benjamin L. Ebert, Michael E. Birnbaum et al.|Science Translational Medicine|2021Cited by 257
Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen ReceptorsMax Jan, Benjamin L. Ebert, Mikołaj Słabicki et al.|Blood|2019Cited by 0